The versatility of health systems in the national COVID-19 response underscore the challenges and opportunities for leaders to strengthen and design systems to better care for communities and respond to ever-changing needs, top health care delivery system leaders outline in a discussion paper for the National Academy of Medicine (NAM).
On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases.
Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.
The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19.
A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine. That was one of the findings reported by a multi-institutional team led by researchers at Washington University School of … Continued
In January 2020, the accelerating spread of SARS-CoV-2 made it apparent that Vanderbilt University Medical Center’s two-bed Contagious Disease Response Unit, created for the rare victim of Ebola or other more-isolated emerging pathogen, would not suffice if Nashville were to be hit hard. So administrators began planning for a major outbreak.
Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19). Patients who received convalescent plasma from donors who had recovered from COVID-19 had a death rate of 13.3% compared to … Continued
Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch (UTMB) at Galveston have discovered what may be the Achilles’ heel of the coronavirus, a finding that may help close the door on COVID-19 and possibly head off future pandemics.
Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences.
COVID-19 patients admitted to intensive care in the early months of the pandemic were subject to a significantly higher burden of delirium and coma than is typically found in patients with acute respiratory failure. Choice of sedative medications and curbs on family visitation played a role in increasing acute brain dysfunction for these patients. That′s according … Continued